Favale E, Rubino V, Mainardi P, Lunardi G, Albano C
Institute of Clinical Neurology, Genoa University, Italy.
Neurology. 1995 Oct;45(10):1926-7. doi: 10.1212/wnl.45.10.1926.
We report an unblinded, open-label, add-on trial of fluoxetine, a selective serotonin reuptake inhibitor, in 17 patients with complex partial seizures with and without secondary generalization (mean follow-up duration, 14 +/- 1.1 months). Six patients showed complete disappearance of their daily seizures; in the others the seizure frequency was lowered by 30%. No patient reported side effects.
我们报告了一项关于选择性5-羟色胺再摄取抑制剂氟西汀的非盲、开放标签、附加试验,该试验纳入了17例伴有或不伴有继发性全身性发作的复杂部分性发作患者(平均随访时长为14±1.1个月)。6例患者的每日癫痫发作完全消失;其他患者的发作频率降低了30%。没有患者报告有副作用。